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A B S T R A C T
Urinary tract infections (UTI) remain one of the most common bacterial infections seen in adult women of all ages. In
postmenopausal women, the aging process contributes to local complaints in the lower urogenital tissue, including UTI.
Our study was conducted at gynecological practices of the health centers in the Zagreb region, Croatia, during 2009. The
study included postmenopausal women with urinary symptoms divided into two groups: hormone therapy (HT) users
and controls. The objectives were to estimate microbiologically proven lower UTIs (LUTIs) in postmenopausal women
with urinary symptoms and the effect of regular HT use on microbiologically confirmed LUTIs. Out of 2338 postmeno-
pausal patients, there was a significantly higher rate of women with urinary symptoms in HT users, namely 64.4%
(143/221), compared to the control group at 4.8% (102/2116). Of the 245 patients with urinary symptoms, in 58.8%
(144/245) the infection was microbiologically confirmed. Hormone therapy users showed a statistically significant lower
rate of microbiologically proven LUTIs (46.9%, 67/143) compared to controls (75.5%, 77/102, p<0.001). Data analysis
also showed the efficacy of local as well as systemic HT treatment compared with the control group (p<0.00, p=0.049).
But there was a significant difference in the frequency of LUTIs between patients who used local (30.3%, 20/66) and sys-
temic (61.1%, 47/77) HT (p<0.001). The patients who, regulary used therapy, in the local HT group as well as in the
group on systemic HT, showed a lower incidence of LUTIs compared to controls (p<0.00, p=0.006). In patients who did
not regulary use therapy , there were no significant differences between either local (63.6%, 7/11) ) or systemic (76. 9%,
20/26) HT non- regular users and the control group (75. 5%, 77/102) (p=0.917, p=0.625). The high percentage of patients
with non-microbiologically confirmed LUTIs (41.2%, 101/245) suggested the significant role microbiological testing has
in LUTI diagnosis. Both local and systemic HT use was related to LUTI reduction.
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Introduction
Urinary tract infections remain one of the most com-
mon bacterial infections seen in adult women of all
ages1,2. The prevalence of symptomatic UTIs or asymp-
tomatic bacteriuria among women is believed to increase
even further with age. Recent prospective studies found
that 10–15% of women over the age of 60 have frequent
recurrences of UTI, with bacteriuria occurring in 10–
15% of women aged 65–70 and 15–20% of women aged
>803,4. In Croatia, acute uncomplicated cystitis in wo-
men occurred more frequently in women over 40 years of
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age, with altogether 65% of episodes of acute uncompli-
cated cystitis recorded in the age group 40–79 years5. Ac-
cording to epidemiological data, this amounts to a total of
825,094 women 50 years, constituting about one third
of all the female population in Croatia6.
After menopause the vagina is more likely to be colo-
nized with potential uropathogens and vaginal pH rises
as the lactobacillus no longer predominates7. Physiologi-
cal changes in the vaginal milieu contribute to UTI in
postmenopausal women8. In order to avoid unnecessary
antibiotic use in patients with UTI, microbiological test-
ing is important.
When UTI is not confirmed by microbiological exami-
nation, the effective treatment option in postmenopausal
women with urinary symptoms could be hormone ther-
apy (HT).
Many studies indicate that estrogen (HT) use may re-
duce recurrent UTI and result in improvements in qual-
ity of life9–12. Regulary use has important role in the posi-
tive effect of HT treatment on UTI. However, rates of use
vary from 9 to 35% for women 40 to 60 years of age13,14.
There are very few available reports on the issue of
postmenopausal health and HT use in Eastern Europe15.
Sales figures in Croatia showed 523,351 prescribed cycles
of postmenopausal hormonal replacement medication
during 2001. Based on these data, one may estimate at
8.3%HT users in the target population of women aged 50
– 6415.
Therefore it was interesting to investigate UTI inci-
dence in postmenopausal women in the Zagreb region, as
well as the relation between UTI and regularity of HT
use. Our investigation comprises lower UTIs (LUTIs):
urethritis, cystitis and urethral syndrome.
In this study, the objectives were to estimate micro-
biologically proven LUTIs in postmenopausal women
with urinary symptoms and investigate the effect of dif-
ferent type of HT regimen regulary used on microbiolo-
gically confirmed LUTIs.
Material and Methods
Study population
The study was carried out at gynecological practices
of the health centers in the Zagreb region, Croatia, dur-
ing 2009. Women aged 45–65 were included in the study.
According to the data given in gynecological practices in
study involved, there were 2338 women aged 45–65. Out
of 2338 patients aged 45–65, there were 222 HRT users
and 2116 non-HRT users. The study included 245 women
who visited the gynecological practices because of uri-
nary symptoms. Each patient had at least two urinary
symptoms (dysuria, nocturnal frequency: 2, diurnal fre-
quency 6, urgency). Exclusion criteria were any syste-
mic disease or infection, suspected or proven malignant
disease, unexplained uterine bleeding, previous hysterec-
tomy or surgical correction in the urogenital tract.
The following specimens for microbiological analysis
were obtained from each patient: urine samples for urine
culture and determination of the number of white blood
cells (leukocytes) in urine sediment, cervicovaginal and
urethral swab specimens. All specimens were obtained
before antibiotic management.
Patients with microbiologically confirmed urethritis,
cystitis or urethral syndrome, or mixed infection were
considered to have LUTI.
In our study, regularity of HT use was defined in ac-
cordance with the answer to the question: »Do you or do
you not forget to take medications once a month at least?«.
All of the patients completed a questionnaire. The ques-
tionnaire covered socio-demographical information (age,
level of education, present occupation, marital and socio-
-economic status), number of pregnancies, onset of meno-
pause, time since last menses in years, urinary symp-
toms, duration of HRT in years, mode of HRT use (tab-
lets, patches, cream, vaginal tablets/cream), regularity of
HT use. All participants provided informed consent, and
the study was approved by the Ethics Committee of the
Croatian National Institute of Public Health.
Microbiological analysis
Microbiological analysis of samples was performed at
the Department of Microbiology and Bacteriology and
the Molecular Diagnostics Department of the Croatian
National Institute of Public Health. Significant bacteri-
uria and the presence of white blood cells in the urine
sediment of symptomatic patients confirmed cystitis16.
The presence of white blood cells in the urine sediment, a
low number of microorganisms in the urine, and the
presence of a single type of bacteria in high numbers in
specimens of urethral swabs of symptomatic patients
confirmed urethral syndrome17. The presence of a genital
mycoplasmas or C. trachomatis in urethral swabs of
symptomatic patients confirmed urethritis17.
All microorganisms cultured from the urine, urethral
or cevicovaginal swabs were identified according to rou-
tine laboratory methods, including API-tests, Bio-Me-
rieux. The diagnosis of urogenital mycoplasmas was con-
firmed by semiquantitative culturing tests Mycofast and
MycoIST; Bio-Merieux and molecular detection was per-
formed using real time PCR methodology on Applied
Biosystems.
C. trachomatis identification was performed using
PCR-Cobas Amplicor methodology by Roche.
Statistical analysis
Statistical analysis was performed by SPSS ver. 17.01
(SPSS ID: 729038). The differences between groups, de-
pending on the type of data, was assessed with paramet-
ric (t-test, ANOVA) or non-parametric (Fisher exact, c2,
Mann-Whitney U or Kruskal-Walis) tests. The level of
statistical significance was chosen to be 0.05.
Results
Out of 2338 patients, 245 (10.4%) postmenopausal
women with urinary symptoms who visited gynecological
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practices during 2009 were included in the study popula-
tion. One hundred and forty-three postmenopausal wo-
men on HT (HT group) and 102 postmenopausal women
with no therapy (control group) completed the study. The
majority of women on HT (77/143, 53.8%) were systemic
(continuously combined or sequentional) therapy users
and 66 women (66/143, 46.1%) were local HT users.
The mean age of the HT patients (N=143) was 57.08±
4.89 years, while that of the control patients (N=102)
was 56.13±5.091 years. There was no statistically signifi-
cant difference between the two study groups regarding
age (p=0.125), onset of menopause (p=0.418), and years
in menopause (p=0.434). The mean number of previous
childbirths per patient was also similar in both groups:
1.68±0.728 for HT patients and 1.58±0.838 for control
patients (p=0.192). Marital status, level of education and
nicotinismus were proportionally similar in both groups
(Table 1).
In the postmenopausal control group there were 102/
2116 (4.8%) women with urinary symptoms, compared to
143/222 (64.4%) in the HT-user group (p<0.001, Table
2). Of the 245 patients with urinary symptoms, an infec-
tious etiology was found for 144/245 (58.8%) patients.
The most frequent microbiologically proven LUTI agents
were Escherichia coli (110/144, 76.3%) and Ureaplasma
urealyticum (101/144, 79.1%).
In the HT patients there was a statistically signifi-
cant lower rate of microbiologically proven LUTIs (67/
143, 46.9%) compared to controls (77/102, 75.5%) (p<
0.001, Table 2).
Furthermore, a comparison between the local HT
and systemic HT users showed a significantly decreased
number of patients with LUTIs in the local HT group
(30.3%, 20/66 vs. 61.1%, 47/77, p<0.001, Table 3).
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TABLE 1
CHARACTERISTICS OF STUDY PATIENTS
Characteristics
HRT – group (N=143)
X±SD*
Control group (N=102)
X±SD
p
Age (years) 57.14±4.898 56.13±5.091 0.125
Menopause (age) 49.97±5.050 49.67±2.611 0.418
Years in menopause 7.10±4.667 6.45±4.041 0.434
No. of children 0.192
Marital status 0.055
Single 1 (0.7 ) 0 (0)
Married 120 (83.9) 92 (90.2)
Widowed 19 (13.3) 5 (4.9)
Divorced 3 (2.1) 5 (4.9)
Level of education 0.052
Low (Primary school) 102 (71.3 ) 61 (59.8)
Intermediate (Secondary school) 36 (25.2) 35 (34.3)
High (University) 5 (3.5) 6 (5.18)
Nicotinismus 1.000
Yes 12 (8.4) 8 (7.8)
No 131 (91.6) 94 (92.2)
Note: Data are no.(%) of subjects or X±SD. * SD=standard deviations
TABLE 2
COMPARISON OF PATIENTS WITH SYMPTOMS AND MICROBIOLOGICALLY PROVEN LUTIs* IN HT USERS AND NON-USERS
Groups of patients
HT users
n/N (%)
HT non-users
n/N (%)
Total
n/N (%)
pa
Urinary symptoms
143/222
(64.4)
102/2116
(4.8)
245/2338
(10.4)
<0.001
Microbiologically* proven LUTIs
67/143
(46.9)
77/102
(75.5)
144/245
(58.4)
<0.001
* Patients with microbiologically proven infections affecting lower urinary tract (cystitis, urethritis, urethral syndrome or mixed in-
fection) among patients with urinary symptoms, n - number of patients with urinary symptoms or LUTIs, N - number of patients in
group
a Comparison of HT users and HT non-users
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Data analysis also showed the efficacy of local as well
as systemic HT treatment compared with the control
group (p<0.001 and p=0.049, Table 3).
There were 106/143 (74.12%) women who use HT
regulary or regulary HT users as compared with 37/143
(25.87%) non-regulary HT users. There was no statistical
difference between the systemic and local HRT groups in
relation to regularity of HT use (48.1%, 51/106 vs. 51.9%,
55/106, p=0.22,Table 4.).
Patients in the local HRT group, as well as the sys-
temic HRT patients who regulary used HT, showed a
lower incidence of LUTIs compared to controls (p<0.001
and p=0.006,Table 4).
There was a statistically significant decrease in the
incidence of LUTIs in patients who regulary used local
HT in comparison to those who regulary used systemic
HT (p=0.003).
In non-regular HT patients, there was no statistical
difference between local and systemic HT users regard-
ing LUTIs (63.6%, 7/11 vs. 76.9%, 20/26, p=0.670). Also,
there were no significant differences between either local
or systemic HT non regular users and the control group
(63.6%, 7/11 vs. 75.5%, 77/102, p=0.917; 76. 9%, 20/26
vs.75.5%, 77/102, p=0.625, Table 4).
Discussion
The aging process in postmenopausal women contrib-
utes to local problems in the lower urogenital tissue, in-
cluding UTI, which adversely affect the quality of the
women’s lives18. In older postmenopausal women, the
clinical presentation of UTI is somewhat different than
in younger women. Postmenopausal women are less like-
ly to report frequency, dysuria, hematuria or fever, but
are more likely to report flank pain19. Also, in postmeno-
pausal women, there are a variety of urogenital com-
plaints and symptoms due to atrophy of the urogenital
mucosa.
In our study, out of 2338 patients between 45 and 65
years of age, 10.4% (245/2338) had urinary symptoms: in
the control group there were only 4.8% (102/2116) wo-
men with urinary symptoms, compared to as many as
64.4% (143/221) in HT users. The possible explanation
for the significantly higher incidence of urinary symp-
toms in HT users is that women who expressed urinary
symptoms visit the doctor more in order to get the HT.
Also, it is possible that HT users are better informed and
generally more concerned about their health.
Despite the fact that an accurate diagnosis of UTI de-
pends on both the presence of symptoms and a positive
urine culture, in most outpatient settings this diagnosis
is made without the benefit of the culture.
Thus, one of the objectives of this study was to esti-
mate the incidence of microbiologically proven LUTI in
postmenopausal women with urinary symptoms.
The results showed that only about half of the post-
menopausal women with urinary symptoms had micro-
biologically proven LUTIs (58.8%, 144/245). In HT pa-
tients there were fewer microbiologically proven LUTIs
compared to controls (46. 9%, 67/143, vs.75.5%, 77/102).
It is possible that the HT patients were not objective in
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TABLE 3
MICROBIOLOGICALLY PROVEN LUTIs* REGARDING TYPE AND REGIMEN OF HT
Groups of
patients
Systemic HT
n/N (%)
Local HT
n/N (%)
Total HT
n/N (%)
Controls
n/N (%)
pa pb pc pd
Total sample
47/77
(61.0)
20/66
(30.3)
67/143
(46.9)
77/102
(75.5)
<0.001 0.049 <0.001 <0.001
a Comparison of systemic and local HT group; b Comparison of systemic HT group and control group; c Comparison of local HT group
and control group; d Comparison of both HT groups and control group
* Patients with microbiologically proven infections affecting lower urinary tract (cystitis, urethritis, urethral syndrome or mixed in-
fection), n - number of patients with LUTIs, N - number of patients in group
TABLE 4
MICROBIOLOGICALLY PROVEN LUTIs* REGARDING REGULARITY OF HT USE
Groups of
patients
Systemic HT
n/N (%)
Local HT
n/N (%)
Total HT
n/N (%)
Controls
n/N (%)
pa pb pc pd
HT regulary used
27/51
(52.5)
13/55
(23.6)
40/106
(37.7)
77/102
(75.5)
0.003 0.006 <0.001 <0.001
HT non-regulary
used
20/26
(76.9)
7/11
(63.6)
27/37
(72.9)
77/102
(75.5)
0.670 0.917 0.623 0.763
a Comparison of systemic and local HT group; b Comparison of systemic HT group and control group; c Comparison of local HT group
and control group; d Comparison of both HT groups and control group
* Patients with microbiologically proven infections affecting lower urinary tract (cystitis, urethritis, urethral syndrome or mixed in-
fection), n - number of patients with LUTIs, N - number of patients in group
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answering the question about urinary symptoms. Also, it
is possible that some of them had urogenital complaints
associated with symptoms of vaginal atrophy or urogeni-
tal aging at the same time. The problem in postmeno-
pausal women is to differentiate urinary symptoms from
those of urogenital aging.
The LUTI incidence in our patients was higher (58.8%,
144/245) compared to Hextall et al.20, who reported the
prevalence of UTIs related to estrogen deficit to range
between 20–30% in the references.
According to our results, in a high percentage of
women (41.2%, 101/245) no infection was microbiologi-
cally proven, despite the urinary symptoms. Also, there
was no significant difference between women with mi-
crobiologically confirmed infection and those with non-
-confirmed infection (58.8%, 144/245 vs. 41.2%, 101/245).
A microbiological analysis is, therefore, necessary for ap-
propriate treatment and avoidance of unnecessary anti-
biotic use.
The second objective was to estimate the impact of
regularity of HT use (including systemic and local mo-
des) on LUTI. According to many investigations21, one of
the benefits of HT is the restoration of lactobacilli vagi-
nal flora associated with a protective effect against uro-
genital infections.
In our study, a significantly lower percentage of LUTIs
was detected in HT users when compared to the control
group (46.9%, 67/143 vs. 75.5%, 77/102, p<0.001). This
result stressed the positive effect of HT treatment on
LUTIs.
Although systemic HRT is frequently used, the role of
oral hormone therapy in reducing urinary infections re-
mains unclear22–24. Many investigators showed that only
local HRT decreased the incidence of LUTIs25,26: random-
ized trials have shown that vaginal estrogen therapy pre-
vents UTI in postmenopausal women with recurring
UTI7,27. The amount of oral hormone that reaches the
vaginal mucosa may be too low to affect the colonization
of uropathogens28. Our study is in accordance with previ-
ously mentioned investigations. Comparing local and
systemic HT use, the result showed that the incidence of
LUTIs was significantly reduced in local HT users as
compared to systemic users (30.3%, 20/66 vs. 61.0%,
47/77, p<0.001), or even compared to controls (30.3%,
20/66 vs. 75.5%, 77/102, p<0.001). Although the compar-
ison between systemic HT users and controls also sho-
wed a statistically significant difference (61.0%, 47/77,
vs. 75.5%, 77/102, p=0.049), it seems that local HT use
was more frequently associated with LUTI reduction.
Hormone replacement medication must be regulary
used and administered strongly according to doctors
presriptions. In the study of Fistoniæ et al.14, the authors
informed about poor persistence with long-term HT in
Croatia. According to our investigation, the majority of
patients were regulary HT users (74.12%, 106/143). The-
re was no statistical difference between the local and sys-
temic HT groups regarding regularity of HT use (51.9%,
55/106 vs. 48.1%, 51/106 p=0.22).
In our study, regulary use resulted in LUTI reduction,
both in local and systemic HT users. Moreover, regulary
local HT users had a significantly lower percentage of
LUTIs than systemic regulary HT users (p=0.003). How-
ever, in non-regular users, there was no statistical differ-
ence between local and systemic HT users with regard to
LUTIs (p=0.670).
The possible reason for high number of regular HT
users is that the study involved women in the metropoli-
tan area of Zagreb, where patients are better informed
about the advantages of HT, have a higher socio-eco-
nomic status and better access to gynecological practices.
However, it is possible that the main limitation of our
study is the generalizability of data, due to the scope of
the metropolitan area population tested.
In conclusion, LUTIs were microbiologically proven
in 58.8% (144/245) of postmenopausal women with uri-
nary symptoms. The high percentage of patients with
non-microbiologically confirmed LUTIs (41.2%, 101/245)
suggested the significant role microbiological testing has
in LUTI diagnosis. Therefore, microbiological analysis is
necessary for appropriate treatment and avoidance of
unnecessary antibiotic use. The incidence of LUTIs was
significantly lower in both groups of HRT users (local
and systemic), and confirmed that HRT use was associ-
ated with LUTI reduction in the population of postmeno-
pausal women in the Zagreb region.
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INFEKCIJE DONJEG DIJELA MOKRA]NOG SUSTAVA I UTJECAJ HORMONSKOG LIJE^ENJA
U @ENA U POSTMENOPAUZI NA PODRU^JU ZAGREBA
S A @ E T A K
Infekcije mokraænog sustava (IMS) spadaju me|u naj~e{æe infekcije `ena svih dobi. Kod `ena u postmenopauzi,
proces starenja doprinosi lokalnim promjenama tkiva donjeg dijela urinarnog sustava, uklju~ujuæi pojavu IMS. Tije-
kom 2009. provedena je prospektivna studija u ginekolo{kim ordinacijama Domova zdravlja na podru~ju Zagreba, na
skupini `ena u postmenopauzi s urinarnim simptomima. Ispitanice su podijeljene u dvije skupine: `ene koje uzimaju
hormonsko lije~enje (HL) i kontrolnu skupinu. Ciljevi ovog rada bili su ustanoviti postotak mikrobiolo{ki dokazanih
infekcija donjeg dijela mokraænog sustava (DIMS) u postmenopauzalnih `ena s urinarnim simptomima i utjecaj HL na
mikrobiolo{ki potvr|ene DIMS kod `ena koje redovito/neredovito uzimaju HL. Od ukupno 2338 `ena, statisti~ki zna-
~ajno vi{e `ena s urinarnim simptomima bilo je u skupini na HL (64,4%, 143/ 221) nego u kontrolnoj skupini (4,8%,
102/2116, p<0,001). Me|utim, od 245 ispitanica s urinarnim simptomima, DIMS je mikrobiolo{ki potvr|ena samo u
58,8% (144/245) od njih. U skupini `ena na HL bilo je statisti~ki zna~ajno manje pacijentica sa mikrobiolo{ki dokaza-
nom DIMS (46,9%, 67/143) u usporedbi s kontrolama (75,5%, 77/102, p<0,001). Utvr|ena je u~inkovitost lokalnog ali i
sistemskog HL u sprje~avanju DIMS u usporedbi s kontrolnom skupinom (p<0,001, p=0,049). Me|utim, u skupini na
HL, izme|u ispitanica na lokalnom (30,3%, 20/66) i sistemskom lije~enju (61,1%, 47/77) ustanovljena je statisti~ki zna-
~ajna razlika u u~estalosti DIMS (p<0,01). U skupini ispitanica koje redovno uzimaju HL, lokalno ili sistemski, tako|er
je ustanovljeno statisti~ki zna~ajno manje DIMS nego u kontrolnoj skupini (p<0,0, p=0,06). U skupini koja neredovno
uzima HNL nije na|ena razlika u u~estalosti DIMS izme|u `ena na lokalnom (63,%, 7/11) ili sistemskom (76,9%, 20/
26) HL te kontrolne skupine (75,5%, 77/102, p=0,917, p=0,625). Obzirom da kod velikog broja ispitanica (41,2%, 101/
245), DIMS nije potvr|ena mikrobiolo{kom pretragom, zaklju~ujemo da je primjena mikrobiolo{ke dijagnostike ne-
ophodna za postavljanje to~ne dijagnoze DIMS. Na smanjenu u~estalost DIMS utjecala je primjena lokalnog ali i sis-
temskog HL.
B. Hunjak et al.: Urinary Tract Infections in Postmenopausal Women, Coll. Antropol. 36 (2012) 3: 841–846
846
U:\coll-antropolo\coll-antro-3-2012\10224 Hunjak.vp
26. rujan 2012 12:51:18
Color profile: Generic CMYK printer profile
Composite  Default screen
